Assessing the safety of del Nido cardioplegia solution in adult congenital cases

Perfusion (United Kingdom)

Volumn 29, Issue 6, 2014, Pages 554-558

  Smigla, G ^a   Jaquiss, R ^a   Walczak, R ^a   Bonadonna, D ^a   Kaemmer, D ^a   Schwimer, C ^a   Lodge, A ^a  

^a DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

adult congenital; cardioplegia; del Nido; ischemic time; myocardial protection

Indexed keywords

ADRENALIN; CARDIOPLEGIC AGENT; DEL NIDO CARDIOPLEGIC AGENT; INOTROPIC AGENT; TROPONIN; UNCLASSIFIED DRUG; CARDIOTONIC AGENT;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONGENITAL HEART DISEASE; DEFIBRILLATION; DRUG SAFETY; ELECTRIC ACTIVITY; HEALTH CARE QUALITY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RHYTHM; HEART SURGERY; HUMAN; OPERATION DURATION; POSTOPERATIVE PERIOD; SINGLE DRUG DOSE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ADOLESCENT; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; HEART DEFECTS, CONGENITAL; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOPLEGIC SOLUTIONS; CARDIOTONIC AGENTS; FEMALE; HEART DEFECTS, CONGENITAL; HEART RATE; HUMANS; MIDDLE AGED; TROPONIN;

EID: 84912000862     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659114543346     Document Type: Article

References (10)

1. Matte GS, del Nido PJ. History and use of del Nido cardioplegia solution at Boston Children's Hospital. JECT. 2012 ; 44: 98-103
2. O'Brien JD, Howlett SE, Burton HJ, O'Blenes SB, Litz DS, Hancock Friesen CL. Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin-t. Ann Thorac Surg. 2009 ; 87: 1517-1524
3. Kronon M, Bolling KS, Allen BS, et al. The relationship between calcium and magnesium in pediatric myocardial protection. J Thorac Cardiovasc Surg. 1997 ; 114: 1010-1019
4. Charette K, Gerrah R, Quaegebeur J, et al. Single dose myocardial protection technique utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion. 2012 ; 27: 98-103
5. Ginther RM, Gorney R, Forbess JM. Use of del Nido cardioplegia solution and a low-prime recirculating cardioplegia circuit in pediatrics. JECT. 2013 ; 45: 46-50
6. Kotani Y, Tweddell J, Gruber P, et al. Current cardioplegia practice in pediatric cardiac surgery: a North American multiinstitutional survey. Ann Thorac Surg. 2013 ; 96: 923-929
7. O'Blenes SB, Friesen CH, Ali A, Howlett S. Protecting the aged heart during cardiac surgery: the potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg. 2011 ; 141: 762-770
8. Govindapillai A, Hua R, Rose R, Friesen C, O'Blenes SB. Protecting the aged heart during cardiac surgery: use of del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg. 2013 ; 146: 940-948
9. Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 1992 ; 38: 386-393
10. Januzzi JL, Lewandrowski K, MacGillivary TE, et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002 ; 39: 1518-1523